Carmen Baldazzi

发表

Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival

C. Finelli, N. Testoni, A. Curti, 2018, Stem Cell Research & Therapy.

Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities

G. Martinelli, A. Cuneo, L. Bonaldi, 2016, Genes, chromosomes & cancer.

WP the definition of complete cytogenetic response : a study of the GIMEMA forfluorescence in situ hybridization and chromosome banding analysis Chronic myeloid leukemia : a prospective comparison of interphase

M. Baccarani, G. Rosti, G. Martinelli, 2009 .

Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP.

C. Carcassi, M. Baccarani, G. Rosti, 2009, Blood.

Chromothripsis in acute myeloid leukemia: biological features and impact on survival

T. Haferlach, M. Steurer, S. Paolini, 2017, Leukemia.

Novel and Rare Fusion Transcripts Involving Transcription Factors and Tumor Suppressor Genes in Acute Myeloid Leukemia

E. Sabattini, B. Huntly, G. Martinelli, 2019, Cancers.

Abstract A27: European Network NGS-PTL preliminary data: Whole exome sequencing identifies mutations of ALDH2, RETSAT, HSPG2, CHPF and other metabolic genes as a novel functional category in acute myeloid leukemia

F. Griggio, L. Riva, P. Pelicci, 2016 .

Acute promyelocytic leukemia with amplification of PML-RARalpha rearrangement: clinical implications.

M. Baccarani, G. Martinelli, E. Ottaviani, 2008, Leukemia research.

Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents

S. Paolini, E. Ottaviani, C. Papayannidis, 2022, European journal of haematology.

Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy

M. Baccarani, G. Rosti, G. Martinelli, 2017, Oncotarget.

t(5;12)(q31;p13)/ETV6::ACSL6 and t(6;9)(p23;q34)/DEK::NUP214 concurrence in acute myeloid leukemia: an unusual association of two rare abnormalities.

A. Grassi, N. Testoni, M. Cavo, 2021, Cancer genetics.

Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implications.

M. Baccarani, G. Rosti, L. Zanatta, 2010, Cancer genetics and cytogenetics.

B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.

M. Baccarani, S. Paolini, G. Martinelli, 2010, Leukemia research.

4q12 translocations with GSX2 expression identify a CD7+ acute myeloid leukaemia subset

C. Mecucci, C. Storlazzi, G. Barba, 2015, British journal of haematology.

Identiﬁcation and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1 –positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell’Adulto Acute Leukemia Working Party (GIMEMAAL WP)

R. Foà, M. Baccarani, S. Chiaretti, 2009 .

MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia

M. Baccarani, S. Paolini, G. Martinelli, 2020, European journal of haematology.

Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients

S. Paolini, G. Martinelli, E. Ottaviani, 2015, Oncotarget.

Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery

G. Castellani, L. Bullinger, T. Haferlach, 2018, Cancer.

Epigenetically induced ectopic expression of UNCX impairs the proliferation and differentiation of myeloid cells

S. Ferrari, T. Mazza, H. Drexler, 2017, Haematologica.

Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).

R. Foà, M. Baccarani, S. Chiaretti, 2009, Blood.

Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis.

M. Baccarani, G. Rosti, G. Martinelli, 2011, Blood.

Working Party on CML analysis adverse prognostic influence on frontline imatinib therapy: a GIMEMA Additional chromosomal abnormalities in Philadelphia-positive clone:

M. Baccarani, G. Rosti, G. Martinelli, 2013 .

Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis.

M. Baccarani, G. Rosti, G. Martinelli, 2012, Blood.

Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival

C. Finelli, N. Testoni, A. Curti, 2018, Stem Cell Research & Therapy.

Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations

G. Castellani, E. Scarpi, T. Haferlach, 2021, Leukemia.

Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients.

S. Paolini, G. Martinelli, E. Ottaviani, 2020, Leukemia research.

Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results

M. Baccarani, G. Rosti, G. Martinelli, 2009, Leukemia & lymphoma.

Emergence of clonal chromosomal abnormalities in Philadelphia negative hematopoiesis in chronic myeloid leukemia patients treated with nilotinib after failure of imatinib therapy.

M. Baccarani, G. Rosti, N. Testoni, 2009, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway

G. Castellani, T. Haferlach, E. Petracci, 2021, Blood Cancer Journal.

Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia

P. Pelicci, E. Sabattini, S. Paolini, 2018, Journal of Hematology & Oncology.

A Prospective Study in Ph+ Chronic Myeloid Leukemia (CML) Patients Showing That Interphase Fluorescence in Situ Hybridization (FISH) Is Effective as Conventional Cytogenetics for Definition of Cytogenetic Response. Correlation with Molecular Response (by the GIMEMA CML WP).

M. Mancini, M. Baccarani, C. Mecucci, 2006 .

The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study

R. Fanin, S. Paolini, E. Ottaviani, 2023, Cancer medicine.

Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50

T. Haferlach, G. Martinelli, M. Delledonne, 2016 .

FGFR1 and KAT6A rearrangements in patients with hematological malignancies and chromosome 8p11 abnormalities: biological and clinical features

S. Paolini, G. Martinelli, C. Papayannidis, 2016, American journal of hematology.

Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway

G. Castellani, T. Haferlach, G. Martinelli, 2021, Blood cancer journal.

CML WP the definition of complete cytogenetic response: a study of the GIMEMA for fluorescence in situ hybridization and chromosome banding analysis Chronic myeloid leukemia: a prospective comparison of interphase

M. Baccarani, G. Rosti, A. Cuneo, 2013 .

Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis.

M. Baccarani, G. Rosti, G. Martinelli, 2011, Blood.